Imbio PHA (4.0.0) vs VX1+
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your primary need is automated, AI-powered analysis of CT pulmonary angiogram (CTPA) scans for rapid assessment of right ventricular dilation. This tool is ideal for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension, providing objective measurements and reports for pre-procedural planning or diagnostic evaluation.
View Imbio PHA (4.0.0) →Choose VX1+ if…
Choose VX1+ if you require real-time, AI-driven assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software is specifically designed to help electrophysiologists identify abnormal electrograms and guide ablation strategies *during* the live procedure, integrating with existing EP recording and 3D mapping systems for immediate insights.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | VX1+ |
|---|---|---|
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
VX1+Tool B, VX1+, offers a 'simple user interface with color coding' and 'real-time manual or automatic annotation' during live cardiac ablation procedures. This direct, intuitive visual guidance in a high-stress, real-time environment provides a critical usability advantage. Tool A, Imbio PHA, focuses on rapid, fully-automated post-processing, which is efficient but less about real-time user interaction during a procedure.
Clinical Value
Imbio PHA (4.0.0)Tool A, Imbio PHA, is FDA-cleared to automatically measure cardiac structures from CTPA scans, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by providing objective, quantitative data like RV/LV and PA/Ao ratios. This offers foundational clinical value by standardizing and enhancing diagnostic capabilities. While Tool B provides real-time assistance during ablation, its specific impact on clinical outcomes (e.g., improved success rates) is not detailed in the provided information.
Pricing & Value
TieNeither Tool A nor Tool B provides publicly available pricing information, making a direct comparison on cost impossible. Both are specialized medical AI tools, and custom enterprise pricing is typical for such solutions. Therefore, a definitive winner cannot be determined for this dimension.
Enterprise Readiness
Imbio PHA (4.0.0)Tool A, Imbio PHA, explicitly states it is HIPAA compliant with third-party certification and offers flexible deployment options including Cloud, Enterprise (on-premise), or via partners. This demonstrates robust readiness for integration into diverse healthcare IT environments. Tool B's compliance is 'expected' rather than explicitly stated and certified, and its deployment is more specific to existing EP systems.
Innovation
VX1+Tool B, VX1+, provides AI-driven insights in real-time during invasive cardiac ablation procedures, assisting electrophysiologists in identifying abnormal electrograms. This real-time, in-procedure guidance represents a higher degree of innovation compared to Tool A's automated post-processing of medical images. The application of AI to directly influence live surgical decision-making is a significant advancement.
Support & Docs
TieThe provided structured facts do not contain any information regarding the availability or quality of support and documentation for either Tool A or Tool B. Public web searches also did not yield specific details for non-customers. Without further information, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | VX1+ |
|---|---|---|
| Name | Imbio PHA (4.0.0) | VX1+ |
| Company | Imbio | Volta Medical |
| Description | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Key Features | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Utilizes artificial intelligence algorithms for anatomical identification and measurement; Generates annotated DICOM images; Provides summary reports in PDF format; Integrates with native DICOM tools and workflows; Rapid, fully-automated assessment (typically in minutes) | Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures; AI-driven insights to assist electrophysiologists during ablation procedures; Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system); Non-sterile reusable medical device; Simple user interface with color coding for electrogram dispersion (blue, orange, red); Booster mode for increased sensitivity during AT or slow AF; Provides cycle length estimation from electrograms |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and VX1+.